Terms: = Leukemia AND PCSK7, Q16549, 9159, ENSG00000160613, PC8, SPC7, PC7, LPC
57 results:
1. Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in patients with acute myeloid leukemia.
Boyd AL; Lu J; Hollands CG; Alsostovar L; Murali S; Reid JC; Ye W; Vandersluis S; Johnson P; ElRafie A; Porras DP; Xenocostas D; Leber A; Leber B; Foley R; Trus M; Berg T; Kawata E; Xenocostas A; Bhatia M
Cell Rep Med; 2023 Jul; 4(7):101108. PubMed ID: 37433297
[TBL] [Abstract] [Full Text] [Related]
2. A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid leukemia Cells.
Guinn BA; Schuler PJ; Schrezenmeier H; Hofmann S; Weiss J; Bulach C; Götz M; Greiner J
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298237
[TBL] [Abstract] [Full Text] [Related]
3. Upregulation of Tim-3 is associated with poor prognosis in acute myeloid leukemia.
Wu Z; Ou J; Liu N; Wang Z; Chen J; Cai Z; Liu X; Yu X; Dai M; Zhou H
Cancer Med; 2023 Apr; 12(7):8956-8969. PubMed ID: 36545697
[TBL] [Abstract] [Full Text] [Related]
4. Enhanced stimulation of antigen-specific immune responses against nucleophosmin 1 mutated acute myeloid leukaemia by an anti-programmed death 1 antibody.
Greiner J; Goetz M; Schuler PJ; Bulach C; Hofmann S; Schrezenmeier H; Dӧhner H; Schneider V; Guinn BA
Br J Haematol; 2022 Sep; 198(5):866-874. PubMed ID: 35799423
[TBL] [Abstract] [Full Text] [Related]
5. Cord-Blood Engraftment Using an Enhanced Dual-Conditioning Regimen for Malignant Hematologic Diseases.
Ding J; Fang Y; Zhou R; Gu Y; Du S; Lu Q; Yue Q
Cell Transplant; 2022; 31():9636897211070238. PubMed ID: 35073786
[TBL] [Abstract] [Full Text] [Related]
6. Investigating the response of paediatric leukaemia-propagating cells to BCL-2 inhibitors.
Diamanti P; Ede BC; Dace PE; Barendt WJ; Cox CV; Hancock JP; Moppett JP; Blair A
Br J Haematol; 2021 Feb; 192(3):577-588. PubMed ID: 32452017
[TBL] [Abstract] [Full Text] [Related]
7. Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibition.
Greiner J; Götz M; Hofmann S; Schrezenmeier H; Wiesneth M; Bullinger L; Döhner H; Schneider V
Cancer Immunol Immunother; 2020 Apr; 69(4):629-640. PubMed ID: 32020256
[TBL] [Abstract] [Full Text] [Related]
8. Transient Receptor Potential Ankyrin 1 Contributes to Lysophosphatidylcholine-Induced Intracellular Calcium Regulation and THP-1-Derived Macrophage Activation.
Tian C; Huang R; Tang F; Lin Z; Cheng N; Han X; Li S; Zhou P; Deng S; Huang H; Zhao H; Xu J; Li Z
J Membr Biol; 2020 Feb; 253(1):43-55. PubMed ID: 31820013
[TBL] [Abstract] [Full Text] [Related]
9. Interference of bone marrow CD56
Theodorakos I; Paterakis G; Papadakis V; Vicha A; Topakas G; Jencova P; Karchilaki E; Taparkou A; Tsagarakis NJ; Polychronopoulou S
Pediatr Blood Cancer; 2019 Aug; 66(8):e27799. PubMed ID: 31066205
[TBL] [Abstract] [Full Text] [Related]
10. Mass spectrometric discrimination of phospholipid patterns in cisplatin-resistant and -sensitive cancer cells.
Cadoni E; Vanhara P; Valletta E; Pinna E; Vascellari S; Caddeo G; Isaia F; Pani A; Havel J; Pivetta T
Rapid Commun Mass Spectrom; 2019 Jan; 33(1):97-106. PubMed ID: 30376198
[TBL] [Abstract] [Full Text] [Related]
11. Bioactive Phospholipids Enhance Migration and Adhesion of Human Leukemic Cells by Inhibiting Heme Oxygenase 1 (HO-1) and Inducible Nitric Oxygenase Synthase (iNOS) in a p38 MAPK-Dependent Manner.
Abdelbaset-Ismail A; Cymer M; Borkowska-Rzeszotek S; Brzeźniakiewicz-Janus K; Rameshwar P; Kakar SS; Ratajczak J; Ratajczak MZ
Stem Cell Rev Rep; 2019 Feb; 15(1):139-154. PubMed ID: 30302660
[TBL] [Abstract] [Full Text] [Related]
12. Clonal selection and asymmetric distribution of human leukemia in murine xenografts revealed by cellular barcoding.
Belderbos ME; Koster T; Ausema B; Jacobs S; Sowdagar S; Zwart E; de Bont E; de Haan G; Bystrykh LV
Blood; 2017 Jun; 129(24):3210-3220. PubMed ID: 28396495
[TBL] [Abstract] [Full Text] [Related]
13. A 5-color flow cytometric method for extended 8-part leukocyte differential.
Guy J; Wagner-Ballon O; Pages O; Bailly F; Borgeot J; Béné MC; Maynadié M
Cytometry B Clin Cytom; 2017 Nov; 92(6):498-507. PubMed ID: 28321976
[TBL] [Abstract] [Full Text] [Related]
14. The significance of peripheral blood minimal residual disease to predict early disease response in patients with B-cell acute lymphoblastic leukemia.
Setiadi A; Owen D; Tsang A; Milner R; Vercauteren S
Int J Lab Hematol; 2016 Oct; 38(5):527-34. PubMed ID: 27339737
[TBL] [Abstract] [Full Text] [Related]
15. RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.
Jajosky AN; Coad JE; Vos JA; Martin KH; Senft JR; Wenger SL; Gibson LF
Stem Cells Transl Med; 2014 Jul; 3(7):836-48. PubMed ID: 24855276
[TBL] [Abstract] [Full Text] [Related]
16. Inactivation of HDAC3 and STAT3 is critically involved in 1-stearoyl-sn-glycero-3-phosphocholine-induced apoptosis in chronic myelogenous leukemia K562 cells.
Jung JH; Jeong SJ; Kim JH; Jung SK; Jung DB; Lee D; Sohn EJ; Yun M; Lee HJ; Lee HJ; Kim SH
Cell Biochem Biophys; 2013; 67(3):1379-89. PubMed ID: 23729004
[TBL] [Abstract] [Full Text] [Related]
17. Immunophenotyping of selected hematologic disorders--focus on lymphoproliferative disorders with more than one malignant cell population.
Porwit A
Int J Lab Hematol; 2013 Jun; 35(3):275-82. PubMed ID: 23590655
[TBL] [Abstract] [Full Text] [Related]
18. Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation.
Ortlepp C; Steudel C; Heiderich C; Koch S; Jacobi A; Ryser M; Brenner S; Bornhäuser M; Brors B; Hofmann WK; Ehninger G; Thiede C
Exp Hematol; 2013 May; 41(5):444-461.e4. PubMed ID: 23377000
[TBL] [Abstract] [Full Text] [Related]
19. Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients.
Mustjoki S; Richter J; Barbany G; Ehrencrona H; Fioretos T; Gedde-Dahl T; Gjertsen BT; Hovland R; Hernesniemi S; Josefsen D; Koskenvesa P; Dybedal I; Markevärn B; Olofsson T; Olsson-Strömberg U; Rapakko K; Thunberg S; Stenke L; Simonsson B; Porkka K; Hjorth-Hansen H;
Leukemia; 2013 Jul; 27(7):1520-6. PubMed ID: 23328954
[TBL] [Abstract] [Full Text] [Related]
20. The use of sequential staining for detection of heterogeneous intracellular response of individual Jurkat cells to lysophosphatidylcholine.
Afrimzon E; Zurgil N; Shafran Y; Leibovich P; Sobolev M; Guejes L; Deutsch M
J Immunol Methods; 2013 Jan; 387(1-2):96-106. PubMed ID: 23063692
[TBL] [Abstract] [Full Text] [Related]
[Next]
